ConductScience.org, home

Paper6416699

Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).

Smith PH and 9 others. Cancer Chemother Pharmacol, 1983. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG). Papers, record 6416699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6416699

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2026-10-11
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith PHP H
2Child JAJ A
3Mulder JHJ H
4Van Oosterom ATA T
5Martinez-Pineiro JAJ A
6Richards BB
7Stoter GG
8Dalesio OO
9De Pauw MM
10Sylvester RR

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Urinary Bladder NeoplasmsMajor topic
Cisplatin
Clinical Trials as Topic
Combined Modality Therapy
Cyclophosphamide
Doxorubicin
Fluorouracil
Follow-Up Studies
Humans
Mitomycin
Mitomycins
Multi-Institutional Systems
Prognosis

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11101401The current status of bladder cancer.Surg Annu1975https://conductscience.org/library/papers/1101401PubMed
2597707The treatment of advanced bladder cancer with methotrexate.Br J Urol1977https://conductscience.org/library/papers/597707PubMed
37194736Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group.Cancer Treat Rep1981https://conductscience.org/library/papers/7194736PubMed
41195468Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.J Urol1975https://conductscience.org/library/papers/1195468PubMed
568814Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.Cancer Res1977https://conductscience.org/library/papers/68814PubMed
6324624Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.Cancer Treat Rep1977https://conductscience.org/library/papers/324624PubMed
77379051Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.Cancer Treat Rep1980https://conductscience.org/library/papers/7379051PubMed
8913456The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil.Eur Urol1977https://conductscience.org/library/papers/913456PubMed
97200890Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/7200890PubMed
107370989Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.Cancer Res1980https://conductscience.org/library/papers/7370989PubMed
117061245Adjuvant chemotherapy and cancer cure.Int J Radiat Oncol Biol Phys1982https://conductscience.org/library/papers/7061245PubMed
12628005Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.J Med Chem1978https://conductscience.org/library/papers/628005PubMed
137044462Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy.Br J Urol1982https://conductscience.org/library/papers/7044462PubMed
147194923The management of advanced bladder carcinoma.J Urol1981https://conductscience.org/library/papers/7194923PubMed
1514346445THE EFFECT OF CYCLOPHOSPHAMIDE ON SOME URINARY TRACT TUMOURS.Br J Urol1965https://conductscience.org/library/papers/14346445PubMed
16657084Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer.Cancer1978https://conductscience.org/library/papers/657084PubMed
177370937Current perspectives in the management of high-grade invasive bladder cancer.Cancer1980https://conductscience.org/library/papers/7370937PubMed
18125624The chemotherapy of urologic cancer.Cancer1975https://conductscience.org/library/papers/125624PubMed
19113879Current concepts in the management of patients with deeply invasive bladder carcinoma.Semin Oncol1979https://conductscience.org/library/papers/113879PubMed
206160912Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract.Cancer Treat Rep1980https://conductscience.org/library/papers/6160912PubMed

See all 36 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
3664943The chemotherapy of advanced bladder cancer.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3664943PubMed
3664942Postoperative systemic adjuvant chemotherapy for bladder cancer.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3664942PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6416699

GET https://conductscience.org/api/papers/v1/6416699/references?page=2